These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30376895)

  • 21. Fatal paraneoplastic systemic leukocytoclastic vasculitis as a presenting feature of chronic lymphocytic leukemia.
    Lulla P; Bandeali S; Baker K
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S14-6. PubMed ID: 22035741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remission of light chain proximal tubulopathy in IgG λ-type multiple myeloma by lenalidomide and dexamethasone therapy.
    Kawamoto S; Hidaka Y; Kaneko Y; Misawa H; Nagahori K; Yoshino A; Okamura T; Ban S; Ueda Y; Takeda T
    CEN Case Rep; 2019 Aug; 8(3):159-165. PubMed ID: 30721454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cutaneous leukocytoclastic vasculitis: about 85 cases].
    Aounallah A; Arouss A; Ghariani N; Saidi W; Sriha B; Denguezli M; Belajouza C; Nouira R
    Pan Afr Med J; 2017; 26():138. PubMed ID: 28533861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatologic Diagnosis: Leukocytoclastic Vasculitis.
    Einhorn J; Levis JT
    Perm J; 2015; 19(3):77-8. PubMed ID: 26176572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bortezomib, lenalidomide, and dexamethasone with panobinostat for front-line treatment of patients with multiple myeloma who are eligible for transplantation: a phase 1 trial.
    Manasanch EE; Shah JJ; Lee HC; Weber DM; Thomas SK; Amini B; Feng L; Berkova Z; Hildebrandt M; Orlowski RZ
    Lancet Haematol; 2018 Dec; 5(12):e628-e640. PubMed ID: 30501870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes.
    Carlson JA; Chen KR
    Am J Dermatopathol; 2006 Dec; 28(6):486-506. PubMed ID: 17122493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple myeloma: Updated approach to management in 2018.
    Tomlinson R
    Aust J Gen Pract; 2018 Aug; 47(8):526-529. PubMed ID: 30114882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare vasculitis flare.
    Hurtado-Garcia R; Jimenez Esteso M; Ruiz-Maciá JA
    Med Clin (Barc); 2017 Sep; 149(6):e30. PubMed ID: 28148396
    [No Abstract]   [Full Text] [Related]  

  • 29. Accelerating Healing and Relieving Pain: High-Intensity Laser Therapy for Paraneoplastic Cutaneous Vasculitis Associated with Multiple Myeloma.
    Felipe Fernandes Maciel K; Cordeiro AH; Fernandes Batista de Amorim R; Bertti Coelho L; de Freitas Cordeiro M; Pinto TDA
    Am J Case Rep; 2024 Feb; 25():e942322. PubMed ID: 38321712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of immunofluorescence testing for vascular IgA in adult patients with leukocytoclastic vasculitis.
    Larson AR; Granter SR
    Am J Clin Pathol; 2014 Sep; 142(3):370-4. PubMed ID: 25125628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
    Caldini A; Nozzoli C; Terreni A; Staderini M; Berardi M; Biagioli T; Brogi M; Bosi A
    Clin Chem Lab Med; 2016 Jun; 54(6):991-5. PubMed ID: 26581069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leukocytoclastic vasculitis].
    Sunderkötter C; Roth J; Bonsmann G
    Hautarzt; 2004 Aug; 55(8):759-83; quiz 784-5. PubMed ID: 15257403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma.
    Cem Ar M; Soysal T; Hatemi G; Salihoglu A; Yazici H; Ulku B
    Ann Hematol; 2005 Sep; 84(9):609-13. PubMed ID: 15906029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Henoch-Schönlein purpura-like vasculitis revealing HIV infection].
    Isnard C; Fardet L; Duriez P; Morin C; Rivière S; Meynard JL; Surgers L
    Med Mal Infect; 2016 Sep; 46(6):322-5. PubMed ID: 27039067
    [No Abstract]   [Full Text] [Related]  

  • 35. [Leukocytoclastic vasculitis: analysis of 62 cases].
    Lozano F; Martín E; Luaces C; Cardellach F
    Med Clin (Barc); 1987 Mar; 88(11):437-41. PubMed ID: 3573846
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous vasculitis as a presenting manifestation of acute myeloid leukemia.
    Jayachandran NV; Thomas J; Chandrasekhara PK; Kanchinadham S; Kadel JK; Narsimulu G
    Int J Rheum Dis; 2009 Apr; 12(1):70-3. PubMed ID: 20374321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [50-year-old patient with leukocytoclastic vasculitis and arthralgia].
    Hennecke T; Harlacher R; Kemper R; Neumann R; Kindler J
    Internist (Berl); 1996 Nov; 37(11):1159-62. PubMed ID: 9036112
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of prior bortezomib therapy on the incidence of lenalidomide-induced skin rash in multiple myeloma: a propensity score-matched multi-institutional cohort study.
    Dote S; Ito K; Itakura S; Yasu T; Hira D; Noda S; Yamada S; Kobayashi Y; Terada T
    Leuk Lymphoma; 2019 Dec; 60(12):2975-2981. PubMed ID: 31046497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature.
    Broccoli A; Gandolfi L; Pellegrini C; Agostinelli C; Argnani L; Zinzani PL
    Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 27002952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical Evidence for the Therapeutic Potential of CD38-Targeted Immuno-Chemotherapy in Multiple Myeloma Patients Refractory to Lenalidomide and Bortezomib.
    Nijhof IS; Groen RW; Noort WA; van Kessel B; de Jong-Korlaar R; Bakker J; van Bueren JJ; Parren PW; Lokhorst HM; van de Donk NW; Martens AC; Mutis T
    Clin Cancer Res; 2015 Jun; 21(12):2802-10. PubMed ID: 25398450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.